Biological Signatures of Asymptomatic Extra- and Intracranial Atherosclerosis
Author(s) -
Elena LópezCancio,
Amparo Galán,
Laura Dorado,
Marta Jiménez,
María Catalina Hernández-Rodas,
Mónica Millán,
Sílvia RevertéVillarroya,
Anna Suñol,
Jaume Barallat,
Anna Massuet,
María Teresa Alzamora,
Antonio Dávalos,
Juan F. Arenillas
Publication year - 2012
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.112.661702
Subject(s) - medicine , asymptomatic , icad , population , cardiology , stroke (engine) , insulin resistance , asymmetric dimethylarginine , metabolic syndrome , dyslipidemia , disease , insulin , obesity , mechanical engineering , biochemistry , chemistry , environmental health , amino acid , arginine , engineering , gene
Intracranial atherosclerotic disease (ICAD) remains a challenge for stroke primary and secondary prevention. Molecular pathways involved in the development of ICAD from its asymptomatic stages are largely unknown. In our population-based study, we aimed to compare the risk factor and biomarker profiles associated with intracranial and extracranial asymptomatic cerebral atherosclerosis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom